Harmony Biosciences To Participate In Three Investor Conferences In September
09/02/2021 - 08:05 AM
PLYMOUTH MEETING, Pa. , Sept. 2, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs , will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:
Citi's 16th Annual BioPharma Virtual Conference 1x1 Meetings: Wednesday and Thursday, September 8-9, 2021 2021 Virtual Wells Fargo Healthcare Conference Fireside Chat: September 10 , 10:40am ET 2021 Cantor Virtual Global Healthcare Conference 1x1 Meetings: Tuesday, September 28, 2021 The live audio webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/ .
About Harmony Biosciences Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com .
Harmony Biosciences Investor Contact: Patti Bank ir@harmonybiosciences.com
Harmony Biosciences Media Contact: nleone@harmonybiosciences.com
https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-three-investor-conferences-in-september-301367935.html
SOURCE Harmony Biosciences
Harmony Biosciences Holdings Inc
HRMY Rankings
#4980 Ranked by Stock Gains
HRMY Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Medicinal and Botanical Manufacturing
About HRMY
patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.
